The race to develop effective treatments for Alzheimer's disease (AD) is one of the most critical challenges facing modern medicine, but clinical trials for AD therapies face enormous hurdles

Artificial Intelligence (AI) this powerful technology, which refers to computer systems designed to mimic human abilities like learning, reasoning, and decision-making, is increasingly finding its way into even the most sensitive areas of medicine, including end-of-life palliative care